Drug Repositioning (Bringing New Life to Shelved Assets and Existing Drugs) || Appendix: Additional Drug Repositioning Resources and Links

Drug Repositioning (Bringing New Life to

Drug Repositioning (Bringing New Life to Shelved Assets and Existing Drugs) || Introduction

✍ Barratt, Michael J.; Frail, Donald E. 📂 Article 📅 2012 🏛 John Wiley & Sons, Inc. 🌐 English ⚖ 47 KB

Drug Repositioning : The Business Case And Current Strategies To Repurpose Shelved Candidates And Marketed Drugs / John Arrowsmith And Richard Harrison -- Opportunities And Challenges Associated With Developing Additional Indications For Clinical Development Candidates And Marketed Drugs / Donald E.

Drug Repositioning (Bringing New Life to

Drug Repositioning (Bringing New Life to Shelved Assets and Existing Drugs) || Regulatory Considerations and Strategies for Drug Repositioning

✍ Barratt, Michael J.; Frail, Donald E. 📂 Article 📅 2012 🏛 John Wiley & Sons, Inc. 🌐 English ⚖ 175 KB

Drug Repositioning : The Business Case And Current Strategies To Repurpose Shelved Candidates And Marketed Drugs / John Arrowsmith And Richard Harrison -- Opportunities And Challenges Associated With Developing Additional Indications For Clinical Development Candidates And Marketed Drugs / Donald E.

Drug Repositioning (Bringing New Life to

Drug Repositioning (Bringing New Life to Shelved Assets and Existing Drugs) || Computational and Bioinformatic Strategies for Drug Repositioning

✍ Barratt, Michael J.; Frail, Donald E. 📂 Article 📅 2012 🏛 John Wiley & Sons, Inc. 🌐 English ⚖ 625 KB

Drug Repositioning : The Business Case And Current Strategies To Repurpose Shelved Candidates And Marketed Drugs / John Arrowsmith And Richard Harrison -- Opportunities And Challenges Associated With Developing Additional Indications For Clinical Development Candidates And Marketed Drugs / Donald E.

Drug Repositioning (Bringing New Life to

Drug Repositioning (Bringing New Life to Shelved Assets and Existing Drugs) || A Case Study in Drug Repositioning: Sosei

✍ Barratt, Michael J.; Frail, Donald E. 📂 Article 📅 2012 🏛 John Wiley & Sons, Inc. 🌐 English ⚖ 105 KB

Drug Repositioning : The Business Case And Current Strategies To Repurpose Shelved Candidates And Marketed Drugs / John Arrowsmith And Richard Harrison -- Opportunities And Challenges Associated With Developing Additional Indications For Clinical Development Candidates And Marketed Drugs / Donald E.

Drug Repositioning (Bringing New Life to

Drug Repositioning (Bringing New Life to Shelved Assets and Existing Drugs) || Business Development Strategies in the Repositioning Industry

✍ Barratt, Michael J.; Frail, Donald E. 📂 Article 📅 2012 🏛 John Wiley & Sons, Inc. 🌐 English ⚖ 76 KB

Drug Repositioning : The Business Case And Current Strategies To Repurpose Shelved Candidates And Marketed Drugs / John Arrowsmith And Richard Harrison -- Opportunities And Challenges Associated With Developing Additional Indications For Clinical Development Candidates And Marketed Drugs / Donald E.

Drug Repositioning (Bringing New Life to

Drug Repositioning (Bringing New Life to Shelved Assets and Existing Drugs) || Clinical and Operational Considerations in Repositioning Marketed Drugs and Drug Candidates

✍ Barratt, Michael J.; Frail, Donald E. 📂 Article 📅 2012 🏛 John Wiley & Sons, Inc. 🌐 English ⚖ 86 KB

Drug Repositioning : The Business Case And Current Strategies To Repurpose Shelved Candidates And Marketed Drugs / John Arrowsmith And Richard Harrison -- Opportunities And Challenges Associated With Developing Additional Indications For Clinical Development Candidates And Marketed Drugs / Donald E.